Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14972526rdf:typepubmed:Citationlld:pubmed
pubmed-article:14972526lifeskim:mentionsumls-concept:C0205725lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0441833lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0023745lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0205396lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C2347644lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:14972526lifeskim:mentionsumls-concept:C1511978lld:lifeskim
pubmed-article:14972526pubmed:issue2lld:pubmed
pubmed-article:14972526pubmed:dateCreated2004-2-19lld:pubmed
pubmed-article:14972526pubmed:abstractTextPreviously, we identified the glycoprotein gO gene, UL74, as a hypervariable locus in the human cytomegalovirus (HCMV) genome [Virology 293 (2002) 281]. Here, we analyze gO from 50 isolates from congenitally infected newborns, transplant recipients, and HIV/AIDS patients from Italy, Australia, and UK. These are compared to four gO groups described from USA transplantation patients [J. Virol. 76 (2002) 10841]. Phylogenetic analyses identified seven genotypes. Divergence between genotypes was up to 55% and within 3%. Discrete linkage was shown between seven hypervariable gO and gN genotypes, but not with gB. This suggests interactions, while gN and gO are known to form complexes with distinct conserved glycoproteins gM, gH/gL, respectively, both are involved in fusogenic entry and exit. Codon-based maximum likelihood models showed evidence for sites of positive selection. Further analyses of disease relationships should take into account these newly defined gO/gN groups.lld:pubmed
pubmed-article:14972526pubmed:languageenglld:pubmed
pubmed-article:14972526pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14972526pubmed:citationSubsetIMlld:pubmed
pubmed-article:14972526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14972526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14972526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14972526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14972526pubmed:statusMEDLINElld:pubmed
pubmed-article:14972526pubmed:monthJanlld:pubmed
pubmed-article:14972526pubmed:issn0042-6822lld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:PollerLLlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:WilkinsonGGlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:Dal MontePPlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:GompelsU AUAlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:RawlinsonWWlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:MattickCClld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:PignatelliSSlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:DewinDDlld:pubmed
pubmed-article:14972526pubmed:authorpubmed-author:Sevilla-Reyes...lld:pubmed
pubmed-article:14972526pubmed:issnTypePrintlld:pubmed
pubmed-article:14972526pubmed:day20lld:pubmed
pubmed-article:14972526pubmed:volume318lld:pubmed
pubmed-article:14972526pubmed:ownerNLMlld:pubmed
pubmed-article:14972526pubmed:authorsCompleteYlld:pubmed
pubmed-article:14972526pubmed:pagination582-97lld:pubmed
pubmed-article:14972526pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:meshHeadingpubmed-meshheading:14972526...lld:pubmed
pubmed-article:14972526pubmed:year2004lld:pubmed
pubmed-article:14972526pubmed:articleTitleLinkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection.lld:pubmed
pubmed-article:14972526pubmed:affiliationDepartment of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, University of London, London WC1E 7HT, UK.lld:pubmed
pubmed-article:14972526pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14972526pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:14972526pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14972526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14972526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14972526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14972526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14972526lld:pubmed